Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT02693535
What this trial is testing

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Who this might be right for
Lymphoma, Non-HodgkinMultiple MyelomaAdvanced Solid Tumors
American Society of Clinical Oncology 4,200
Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Early research (Phase 1)Study completedNCT02598570
What this trial is testing

Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma

Who this might be right for
Lymphoma
AbbVie 7
Not applicableUnknownNCT05639673
What this trial is testing

Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Rigshospitalet, Denmark 5,000
Large-scale testing (Phase 3)Active Not RecruitingNCT00572169
What this trial is testing

UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy

Who this might be right for
Multiple Myeloma
University of Arkansas 177
Not applicableNot Yet RecruitingNCT07669194
What this trial is testing

Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Early research (Phase 1)Ended earlyNCT00023166
What this trial is testing

Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas

Who this might be right for
NeoplasmLymphomasNeoplasm Metastasis
Enzon Pharmaceuticals, Inc.
Not applicableStudy completedNCT00911105
What this trial is testing

Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone

Who this might be right for
Multiple Myeloma
iOMEDICO AG 101
Testing effectiveness (Phase 2)Looking for participantsNCT06563505
What this trial is testing

Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 36
Not applicableStudy completedNCT03472105
What this trial is testing

Short-term Effect of a New Nordic Renal Diet on Phosphorus Homeostasis in CKD Stage 3-4

Who this might be right for
Chronic Kidney Disease, Stage 3 (Moderate)
University of Copenhagen 18
Not applicableStudy completedNCT00274794
What this trial is testing

VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL

Who this might be right for
Lymphoma
The Cleveland Clinic 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT05627856
What this trial is testing

GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL

Who this might be right for
NK/T Cell LymphomaVascular Immunomother T Cell LymphomaNon-Hodgkin Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd. 4
Large-scale testing (Phase 3)Looking for participantsNCT06082102
What this trial is testing

Efficacy and Safety of Orelabrutinib Combined With Rituximab Versus Lenalidomide Combined With Rituximab in Patients With Relapsed/Refractory Marginal Zone Lymphoma

Who this might be right for
Relapsed/Refractory Marginal Zone Lymphoma
Beijing InnoCare Pharma Tech Co., Ltd. 324
Early research (Phase 1)Study completedNCT00458653
What this trial is testing

Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Beth Israel Deaconess Medical Center 45
Testing effectiveness (Phase 2)Ended earlyNCT01103037
What this trial is testing

Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 8
Not applicableStudy completedNCT00159003
What this trial is testing

Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia
Deborah Rund 100
Not applicableStudy completedNCT00569842
What this trial is testing

Investigation of the Cylex® ImmuKnow® Assay

Who this might be right for
LeukemiaNon-Hodgkin's LymphomaChronic Lymphocytic Leukemia+6 more
Indiana University 45
Testing effectiveness (Phase 2)Study completedNCT00716651
What this trial is testing

Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome

Who this might be right for
Churg Strauss Syndrome
University Hospital Schleswig-Holstein 10
Testing effectiveness (Phase 2)Study completedNCT00106431
What this trial is testing

A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)

Who this might be right for
Cutaneous T-cell Lymphoma
Celgene 102
Testing effectiveness (Phase 2)Study completedNCT00433745
What this trial is testing

Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)
National Heart, Lung, and Blood Institute (NHLBI) 4
Next Page